Take Home Points from the 2013 Liver Meeting

Summarizing last week’s annual Liver Meeting is like telling one of those good news/bad news stories. In this post, I’ll begin with the “good news.” The “bad news” will be in the next post. My Favorite News Direct-acting antivirals (DAAs) are changing the landscape of hepatitis C treatment. The good news is plentiful—short, effective all-oral […]